Advertisement Immucor completes acquisition of BioArray Solutions - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Immucor completes acquisition of BioArray Solutions

Immucor, a provider of automated instrument-reagent systems to the blood transfusion industry, has closed its previously announced acquisition of BioArray Solutions.

Gioacchino Chirico, president and CEO of Immucor, said: “We are pleased to have completed this acquisition, which we believe will enable us to provide innovative molecular diagnostic solutions for blood transfusions to enhance patient outcomes.”